It has been observed that treatment with AGTR1 antagonists significantly reduces the total UPDRS score after one year in PD patients with hypertension, whereas this effect is not observed in patients receiving angiotensin-converting enzyme (ACE) inhibitor treatment [41]. This evidence concerns the gene AGTR1 and hypertensive disorder.